Member Info for chester18

Hi Chelsea7

Wish you all the best for tomorrow, we are so close to a fundamental RNS that I would like you to be home and fully engaged in the debate, so be strong and be determined to be ready to discuss the promised Mabs deal.

We don't know if its going to be a 'hand shake gentleman's deal' or a proper £5m upfront with bells on deal. What I do know is your involvement in the discussion is what this board thrives on.

Chester.

Hi KJM100K

Agreed, Gareth Jones did say that the new 'White Label Goods' contract would eventually be worth £30m pa. on its own but we need to develop the infrastructure to produce both the organic growth and the White Label deal.

My reasoning is that putting Covid to one side we could reach £24m T/O in full year 2021 and £30 to £40m in full year 2022. I would think that the greater turnover off £50/ £60m will not happen until 2023. I might be being a bit pessimistic but the build up to that amount of sales can only happen with further investment in the manufacturing infrastructure. Probably a third factory in San Antonio or a new facility in the UK.

There will be a tipping point where the revenue will provide enough flexibility to enable organic growth that will create further revenue and further growth.
If we can retain the margin at 48% the company will be a revenue creating machine and will produce yearly dividends that will drive the SP higher and higher. I'm talking 2024 / 2025.

Chester.

Having read the full report my resolve to hold TRX long term has been strengthened.

The only negative is how deeply the pandemic affects elective surgery.

Pandemic aside we will see growth in production during early 2021 and then once phase 2 of the fit out is complete turnover will exceed £36m pa. which means healthy profits as the margin is currently 48.3%.

On the core of the business and the focus of the BOD this Hardman report is excellent.

We need an effective Covid vaccine by next May so we can all get back to some kind of normal life.

Chester.

Morning ShearClass

Yes that £110m MCap I remember well....

I was taken aback by the last placing, the number of new shares and the price.
I unfortunately missed the opportunity to load up at 0.25p so had to sell 50% of my holding at roughly 0.45p on the hope that the price would go down and it did so I got back in at 0.31p and have added ever since.

We hold shares in a very interesting company, notably their products fit with an ever growing market.

This shift in price does feel like the real thing so I'm hoping that we establish a new base around 0.4 to 0.43p. If that happens before any pivitol news then I can see 0.6p by December. Then its just all about progress on the sales and manufacturing, we could continually grow for the next 10 years the market is going to be that large.

Chester.

Take Two '''''''' Action ....

I was totally convinced that we would see the 'Aerial Magnetics' results this week and because GH likes his Tuesday RNS'es I thought today would have been perfect.

So what possible reason could there be to hold back those results ?

Chester ( I know my place )

Ok, just noticed 'Aerial Magnetics' ........ I'll get my Coat .......

Chester.

No, it's a guide to the 'One way System' around Chester Town Centre ........ : )

I was totally convinced that we would see the Ariel Magnetics results this week and because GH likes his Tuesday RNS'es I thought today would have been perfect.

So what possible reason could there be to hold back those results ?

'WWW.Confused.Chester'

I have re-read the 24th August 'OrthoPure XT' RNS and that one product is a great example of the time it takes to bring a product to market and then to begin to establish a production pipeline. The surgical trials to obtain the European 'CE Mark' took three years and the standard needed to be past was "safety at two years, with maintenance of knee function".

"OrthoPure® XT is a decellularized porcine tendon, developed using the Group's patented dCELL® technology. It was granted CE Mark approval for the reconstruction of knee ligaments to restore knee function and stability".

This will become a huge product line in the coming years but it will take until early 2021 before TRX has built up the UK baseline and can then start to roll it out across Europe and even then they will have to pick their spots.

"Tissue Regenix's OrthoPure™ XT has been developed as an effective and cost-efficient solution to ACL rupture which is the second most common injury of the knee requiring reconstruction, around 900,000 ACL procedures performed in the US & Europe in 2014".

I have no idea what such a product could be charged out at but just taking a guess at £700 per packaged tendon, which I'm presuming is a reasonable price, if TRX could distribute 30,000 units per year (2,500 per month) the demand for that one product could be £20m per annum.

As you can see the upscale is enormous, it will take time to establish both the markets and the manufacturing but once in place this business will be worth £100's of millions.

Lets not forget, BioRinse, BioSurge, DurmaPure, SurgePure XD, DentalFix, MatrixCellect 100 DBM, Matrix OI, ConCelltrate 100 .......... I may have missed some. All of the above are in demand and in High growth areas of medical need.

There is a lot to be positive about now they have the cash to make it happen.

Chester.

So we now know that last years figures will be out on the 16th which means that the AGM will also be announced. The latest SCLP has been with an AGM is was back in 2013 and that was the 1st November. With it being a Virtual AGM I would imagine they won't need to give 21 days notice so my instinct is a date around the 28th October.

What I'm leading up to is does this mean that the potential Mabs deal will be announced just before the AGM meaning that CH hits his one to two months statement on the 27th August - Proactive Investors 'One to One'.

We keep on hearing that SCLP need to start keeping to their promised delivery dates and that one is about to be tested.

Chester.

If I wanted the maximum effect out of the Ariel mags I would definitely RNS this week followed by Scally at the back end of next week, leaving 10 days run up to the Newcrest 11th out of 11 stunning drill core results.

To me that chain of news would create the maximum upward pressure on the SP.
Plus it would keep us lot on our toes......

Chester.

Setting up for the Scallywag initial snippets, will we see the Ariel Magnetics this Tuesday with Scally next week or will GH hold back until closer to the quarterly report ?

Chester.

Good afternoon 'a most unusually quiet board this morning',

There is reason to believe that this week we will see an RNS for both the Full Year Accounts and therefore the official date of the AGM.

My take is that both these news worthy items have been pushed back as far as possible to enable ink to be applied to paper.

Could be a very interesting week because if we don't hear anything then its all being compressed into just a few weeks, then we will have to ask ourselves, why.

Chester.

Sorry I was answering HBomb5's question...... : )

Hi Andysmi

Just off the top of my head, OrthoPure XT has been approved in Europe and needs to be upscaled and rolled out. TRX will seek US approval I'm presuming in 2021.

Gareth Jones did say that they had to concentrate on Biorinse because the demand was continuous right through the peak of the pandemic April to June, so they backed off production of Demapure in-house and I'm sure we are still out sourcing that product while the San Antonio facility is upgraded.

A new product can just be a range of new thicker patches or the size of patch to address a new surgical procedure. If you think of the numerous area's of the human body that wear out or get damaged and need repair, TRX can produce hundreds of new 'products' once that demand has been identified by surgeons.

The growth potential in the regenerative / replacement tissue market is huge with a capital 'H'.

Chester.

Anyone putting money into shares as an investment knows that there is a possibility that the money will just drain away.

I'm sure that everyone who debates Scancell on this board is probably over 18 years old and hopefully be in charge of some of their faculties.

You need, attention to the details, the ability to do research and use critical thinking, put that together with an understanding of the company history and the calibre of the management team, plus as much knowledge as possible as to what the company is doing, what it owns and what it offers.

My research, understanding and critical thinking about Scancell allowed me to buy a substantial amount of shares below 5.5p while those who don't understand what they have invested in worried about why market sentiment was holding the price down.

RISK :

R.esearch before you Buy.
I.n-depth understanding of who the company are and what is their likely potential.
S.trategy, why are you investing, what is your goal.
K.nowledge, of the any Products, Approvals, Intellectual property or Granted patents.

So I have no time for gamblers or piggyback punters who buy on a whim.

Do your research, invest what you can afford to lose and good luck, you should not need your hand to be held.

Chester.

Hi Aurora1

maybe its a bit late in the day but I'm not fully understanding your point.

Chester.

Cheers for that.

I have enjoyed the journey 100% but do feel very lucky to have looked into Greatland Gold so early in the Havieron find.
Its a once in a lifetime investment and doesn't usually happen for the man in the street investor.

good luck to your good self in all your endeavours,

Chester.

thedoors,

totally agree. We are unbelievably lucky to aware of GGP and able to buy some shares. I don't know about yourself but I've been here since the Newmont disappointment and ended up with some (shares not as many as some) at 1.8p.
This is still an evolving story and if Scallywag has some buried treasure be it gold or copper it will be like winning the lotto twice.....lol

lets hope my Lucky 63 hits the next the spot, it would be so much fun if it keeps on hitting the right levels........ ATB

Chester.

@jimjam

A bold move sir..... noted

Chester..... : )